Literature DB >> 21505076

Allelic reduction of Dlx5 and Dlx6 results in early follicular depletion: a new mouse model of primary ovarian insufficiency.

Kamal Bouhali1, Aurélie Dipietromaria, Anastasia Fontaine, Sandrine Caburet, Ottavia Barbieri, Brice Bellessort, Marc Fellous, Reiner A Veitia, Giovanni Levi.   

Abstract

Primary ovarian insufficiency (POI) is characterized by the loss of ovarian function before the age of 40 in humans. Although most cases of POI are idiopathic, many are familial, underlying a genetic origin of the disease. Mutations in genes involved in the control of steroidogenesis, such as NR5A1 (SF-1, Steroidogenic Factor 1), CYP17, CYP19A1 (aromatase), StAR (Steroidogenic Acute Regulatory), and the forkhead transcription factor FOXL2 have been associated with different forms of POI. In males, the homeobox transcription factors Dlx5 and Dlx6 are involved in the control of steroidogenesis through the activation of GATA4-induced-StAR transcription. Here, we analyze the potential involvement of Dlx5 and Dlx6 in female reproduction. To this end, we make use of an existing mouse model in which Dlx5 and Dlx6 are simultaneously disrupted. We show that: (i) allelic reduction of Dlx5 and Dlx6 in the mouse results in a POI-like phenotype, characterized by reduced fertility and early follicular exhaustion; (ii) in granulosa cell lines, a reciprocal regulation exists between Dlx5 and Foxl2; (iii) in the mouse ovary, allelic reduction of Dlx5/6 results in the upregulation of Foxl2. We propose that the mutual regulation between Dlx5/6 and Foxl2 and their opposite effects on StAR expression might contribute to determine the homeostatic control of steroidogenesis within the ovary. Dysregulation of this homeostatic control would result in abnormal follicular maturation and reduced fertility. Our results bring new elements to our conceptual model of follicle maturation and maintenance and provide new potential genetic targets for cases of familial POI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21505076     DOI: 10.1093/hmg/ddr166

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  7 in total

1.  A mouse model of premature ovarian insufficiency induced by tripterygium glycoside via subcutaneous injection.

Authors:  Xiu-Ying Chen; Chao Gu; Min Ma; Qing Cong; Ting Guo; Duan Ma; Bin Li
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

2.  Optimizing Nervous System-Specific Gene Targeting with Cre Driver Lines: Prevalence of Germline Recombination and Influencing Factors.

Authors:  Lin Luo; Mateusz C Ambrozkiewicz; Fritz Benseler; Cui Chen; Emilie Dumontier; Susanne Falkner; Elisabetta Furlanis; Andrea M Gomez; Naosuke Hoshina; Wei-Hsiang Huang; Mary Anne Hutchison; Yu Itoh-Maruoka; Laura A Lavery; Wei Li; Tomohiko Maruo; Junko Motohashi; Emily Ling-Lin Pai; Kenneth A Pelkey; Ariane Pereira; Thomas Philips; Jennifer L Sinclair; Jeff A Stogsdill; Lisa Traunmüller; Jiexin Wang; Joke Wortel; Wenjia You; Nashat Abumaria; Kevin T Beier; Nils Brose; Harold A Burgess; Constance L Cepko; Jean-François Cloutier; Cagla Eroglu; Sandra Goebbels; Pascal S Kaeser; Jeremy N Kay; Wei Lu; Liqun Luo; Kenji Mandai; Chris J McBain; Klaus-Armin Nave; Marco A M Prado; Vania F Prado; Jeffrey Rothstein; John L R Rubenstein; Gesine Saher; Kenji Sakimura; Joshua R Sanes; Peter Scheiffele; Yoshimi Takai; Hisashi Umemori; Matthijs Verhage; Michisuke Yuzaki; Huda Yahya Zoghbi; Hiroshi Kawabe; Ann Marie Craig
Journal:  Neuron       Date:  2020-02-05       Impact factor: 17.173

3.  Genome-wide linkage in a highly consanguineous pedigree reveals two novel loci on chromosome 7 for non-syndromic familial Premature Ovarian Failure.

Authors:  Sandrine Caburet; Petra Zavadakova; Ziva Ben-Neriah; Kamal Bouhali; Aurélie Dipietromaria; Céline Charon; Céline Besse; Paul Laissue; Vered Chalifa-Caspi; Sophie Christin-Maitre; Daniel Vaiman; Giovanni Levi; Reiner A Veitia; Marc Fellous
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

Review 4.  Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI).

Authors:  Stephanie L Sherman; Eliza C Curnow; Charles A Easley; Peng Jin; Renate K Hukema; Maria Isabel Tejada; Rob Willemsen; Karen Usdin
Journal:  J Neurodev Disord       Date:  2014-08-13       Impact factor: 4.025

Review 5.  Application of Perinatal Derivatives in Ovarian Diseases.

Authors:  Anna Lange-Consiglio; Emanuele Capra; Valentina Herrera; Ingrid Lang-Olip; Peter Ponsaerts; Fausto Cremonesi
Journal:  Front Bioeng Biotechnol       Date:  2022-01-24

6.  Ecology drives intragenomic conflict over menopause.

Authors:  Francisco Úbeda; Hisashi Ohtsuki; Andy Gardner
Journal:  Ecol Lett       Date:  2013-12-09       Impact factor: 9.492

7.  Comparative analysis of molecular signatures suggests the use of gabapentin for the management of endometriosis-associated pain.

Authors:  Brice Bellessort; Anne Bachelot; Virginie Grouthier; Camille De Lombares; Nicolas Narboux-Neme; Paolo Garagnani; Chiara Pirazzini; Simonetta Astigiano; Luca Mastracci; Anastasia Fontaine; Gladys Alfama; Evelyne Duvernois-Berthet; Giovanni Levi
Journal:  J Pain Res       Date:  2018-04-10       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.